Call us at: 1.866.416.4636 | Europe: +800.0751.2020

Preclinical
Clinical

Events

News Releases

Toronto,Ontario. – January 26, 2006 – Paving the way for its entry into the molecular imaging market, VisualSonics, the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, today announced that it is in-licensing a contrast agent for the quantification of myocardial perfusion in preclinical studies from the University of Virginia.
Toronto, Ontario – January 23, 2006 – VisualSonics, the world’s leading developer of high resolution, micro-ultrasound-based in vivo imaging systems for preclinical research, today announced that its quality management system has been registered as complying with the requirements of ISO 9001:2000.
TORONTO, CANADA - May 25, 2005 - VisualSonics and the Vevo 770® high-resolution micro-ultrasound is featured in the May 25th, 2005 issue of The Scientist. 
Toronto, Canada, January 11, 2002 - Today, VisualSonics, the leader in high frequency ultrasound imaging technology, introduced to the world its proprietary new RMVTM technology which offers the first real-time, high frequency encapsulated transducer.
Share

Request a Quote or Demo

Contact Us